Trasicor (39,089/Ba) in angina pectoris. A single-blind trial.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy* / Q000209:etiology; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001024:Aortic Valve Stenosis / Q000150:complications; D001919:Bradycardia / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000150:complications; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D010919:Placebos; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D010919:Placebos; D013565:Sympatholytics